Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
about
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.The antiangiogenic role of the pro-inflammatory cytokine interleukin-31.To b(ortezomib) or not to be: the stroma's the thing.Bone marrow myeloid cells in regulation of multiple myeloma progression.PSMB5 plays a dual role in cancer development and immunosuppression.Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach.
P2860
Q33628057-D47DE99A-02EA-4078-92F7-044B8168FC29Q37725449-D86379D6-FDDC-4263-ADC7-398C12B4B09CQ38762531-2620A1FC-1D7B-4C84-A3E0-A6745C05FDF5Q39220773-A4B67B1C-16A2-48B3-B97E-B9A3087E41C3Q47347202-C4F15DC7-39F5-4586-A1C2-B631F4349A31Q48507691-93C7DA4E-31C4-4B07-8EBE-A84FD5BD22F3Q49636757-4AF08FF2-43FD-409F-88E1-85D6D09430B4
P2860
Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bortezomib-induced pro-inflamm ...... limiting anti-tumour efficacy.
@en
type
label
Bortezomib-induced pro-inflamm ...... limiting anti-tumour efficacy.
@en
prefLabel
Bortezomib-induced pro-inflamm ...... limiting anti-tumour efficacy.
@en
P2093
P2860
P356
P1476
Bortezomib-induced pro-inflamm ...... limiting anti-tumour efficacy.
@en
P2093
Dror Alishekevitz
Irit Avivi
Ksenia Magidey
Michael Timaner
Moshit Lindzen
Neta Ben-Tsedek
Ofrat Beyar-Katz
Valeria Miller
Yosef Yarden
Yuval Shaked
P2860
P304
P356
10.1002/PATH.4723
P577
2016-04-01T00:00:00Z